Physiopathology of symptoms and signs in multiple sclerosis
- PMID: 22990733
- DOI: 10.1590/s0004-282x2012000900016
Physiopathology of symptoms and signs in multiple sclerosis
Abstract
The physiopathology of symptoms and signs in multiple sclerosis (MS) is a less divulged topic albeit its importance in the patients' management.
Objective: It was to summarize the main biophysical and biochemical mechanisms which produce the clinical manifestations in MS.
Results: The mechanisms underpinning neurological deficits are described in the relapsing and in the progressive phases, stressing inflammatory and neurodegenerative components, especially demyelination, axonal damage and conduction impairment. Transient worsening based in Uhthoff's phenomenon, mechanisms producing positive symptoms, as paraesthesias and Lhermitte sign due to axonal hyperexcitability and ephaptic interactions, and development of cortical symptoms will also be addressed. The variety of processes leading to neural repair and functional recovery in the remitting phase is focused, as remyelination and adaptive changes due to neural plasticity.
Conclusion: The awareness of mechanisms producing symptoms in MS emphasises the role of symptomatic and rehabilitation therapies in the improvement of patients' well-being.
Similar articles
-
The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1649-73. doi: 10.1098/rstb.1999.0510. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603618 Free PMC article. Review.
-
[Pathophysiology of multiple sclerosis].Rev Prat. 2006 Jun 30;56(12):1299-303. Rev Prat. 2006. PMID: 16948217 Review. French.
-
Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.J Neuropathol Exp Neurol. 2002 Jan;61(1):23-32. doi: 10.1093/jnen/61.1.23. J Neuropathol Exp Neurol. 2002. PMID: 11829341
-
Relating axonal injury to functional recovery in MS.Neurology. 2000 Jan 11;54(1):236-9. doi: 10.1212/wnl.54.1.236. Neurology. 2000. PMID: 10636158
-
Cortical plasticity predicts recovery from relapse in multiple sclerosis.Mult Scler. 2014 Apr;20(4):451-7. doi: 10.1177/1352458513512541. Epub 2013 Nov 21. Mult Scler. 2014. PMID: 24263385
Cited by
-
Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis.CNS Drugs. 2024 Mar;38(3):205-224. doi: 10.1007/s40263-024-01072-5. Epub 2024 Feb 29. CNS Drugs. 2024. PMID: 38421578 Review.
-
Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model.Front Mol Med. 2023;3:1237078. doi: 10.3389/fmmed.2023.1237078. Epub 2023 Aug 28. Front Mol Med. 2023. PMID: 37933270 Free PMC article.
-
Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.PLoS One. 2023 Oct 18;18(10):e0292233. doi: 10.1371/journal.pone.0292233. eCollection 2023. PLoS One. 2023. PMID: 37851620 Free PMC article.
-
Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action.Front Pharmacol. 2022 May 9;13:908198. doi: 10.3389/fphar.2022.908198. eCollection 2022. Front Pharmacol. 2022. PMID: 35614947 Free PMC article. Review.
-
Trichostatin A Promotes the Conversion of Astrocytes to Oligodendrocyte Progenitors in a Defined Culture Medium.Iran J Pharm Res. 2019 Winter;18(1):286-295. Iran J Pharm Res. 2019. PMID: 31089363 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
